Prognostic impact of discordance in hormone receptor status after the neoadjuvant chemotherapy in primary breast cancer

被引：0
|
作者：
Kurihara, Toshiaki [1 ]
Ueno, Hanako [1 ]
Takemae, Masaru [1 ]
Nagayama, Aiko [1 ]
Takahashi, Maiko [1 ]
Hayashida, Tetsu [1 ]
Jinno, Hiromitsu [1 ]
Kitagawa, Yuko [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo 108, Japan
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P3-06-49
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-06-49
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discordance in hormone receptor and HER2 status in breast cancer during neoadjuvant chemotherapy
    Maeda, S.
    Tohyama, H.
    Tokai, H.
    Kamohara, Y.
    Nagata, Y.
    Fujioka, H.
    Itoh, M.
    BREAST, 2011, 20 : S73 - S73
  • [2] CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER
    Ustaalioglu, B. B. Oven
    Vardar, F. Aker
    Bilici, A.
    Gurleyik, G.
    Erkol, B.
    Kefeli, U.
    ANNALS OF ONCOLOGY, 2014, 25
  • [3] Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer
    Shiino, Sho
    Kinoshita, Takayuki
    Yoshida, Masayuki
    Jimbo, Kenjiro
    Asaga, Sota
    Takayama, Shin
    Tsuda, Hitoshi
    CLINICAL BREAST CANCER, 2016, 16 (04) : E133 - E140
  • [4] Prognostic significance of biomarker discordance after neoadjuvant chemotherapy in breast cancer
    Matsumoto, A.
    Jinno, H.
    Ando, T.
    Fujii, T.
    Nakamura, T.
    Saito, J.
    Takahashi, M.
    Hayashida, T.
    Kitagawa, Y.
    BREAST, 2015, 24 : S96 - S97
  • [5] Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor–positive Breast Cancer
    Sheng Chen
    Can-Ming Chen
    Ke-Da Yu
    Ruo-Ji Zhou
    Zhi-Ming Shao
    Annals of Surgical Oncology, 2012, 19 : 3002 - 3011
  • [6] Change in HER2 status after neoadjuvant chemotherapy and the prognostic impact in patients with primary breast cancer
    Yoshida, Atsushi
    Hayashi, Naoki
    Suzuki, Koyu
    Takimoto, Masafumi
    Nakamura, Seigo
    Yamauchi, Hideko
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (08) : 1021 - 1028
  • [7] The negative prognostic impact of downstaging after neoadjuvant chemotherapy in patients with hormone-receptor positive breast cancer.
    Takahashi, Yuko
    Hayashi, Naoki
    Matsuda, Naoko
    Kajiura, Yuka
    Yoshida, Atsushi
    Yagata, Hiroshi
    Nakamura, Seigo
    Suzuki, Koyu
    Tsunoda, Hiroko
    Yamauchi, Hideko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor-positive Breast Cancer
    Chen, Sheng
    Chen, Can-Ming
    Yu, Ke-Da
    Zhou, Ruo-Ji
    Shao, Zhi-Ming
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) : 3002 - 3011
  • [9] Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy
    Sanjit Kumar Agrawal
    Sanjoy Chatterjee
    Indu Arun
    Rosina Ahmed
    Indian Journal of Surgical Oncology, 2017, 8 (2) : 245 - 246
  • [10] Changes in Hormone Receptor and Her2 Status After Neoadjuvant Chemotherapy in Breast Cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Yamac, Deniz
    Coskun, Ugur
    Yildiz, Ramazan
    Yaman, Emel
    Ozturk, Banu
    Benekli, Mustafa
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2010, 30 (02): : 469 - 473
12345